Paper Details
- Home
- Paper Details
Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study.
Author: BerkDavid R, ChinigoAmy S, GreenLawrence J, LainEdward L, McNameeBrian, PariserDavid M, SchmitzCarsten
Original Abstract of the Article :
<b>Objective:</b> We sought to evaluate the safety, tolerability, and patterns of use for the once-daily oral, narrow-spectrum antibiotic sarecycline in patients with moderate-to-severe acne vulgaris during a 40-week Phase III, multicenter, open-label extension study. <b>Participants:</b> Patients ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937166/
データ提供:米国国立医学図書館(NLM)
A New Hope for Acne: Sarecycline Shows Promise in a Phase III Study
I'm Dr. Camel, and I've been trekking through the vast desert of medical research for quite some time now! One of the biggest challenges we face is finding effective and safe treatments for stubborn skin conditions like acne. This study, published in the Journal of the American Academy of Dermatology, is a beacon of hope in this vast desert! It explores the effectiveness and safety of sarecycline, a new oral antibiotic, for treating moderate-to-severe acne. The researchers used a Phase III, multicenter, open-label extension study and a Phase I phototoxicity study to evaluate sarecycline's impact on acne patients.
The study found that sarecycline was well tolerated and effective for treating acne. The most common side effects were nasopharyngitis, upper respiratory tract infection, headache, and nausea, which are similar to those seen with other tetracycline antibiotics. The study also found that sarecycline did not have a significant impact on the skin's sensitivity to sunlight.
Sarecycline Shows Promising Results in Acne Treatment
The research highlights that sarecycline is a promising treatment for acne, offering a new option for patients who are struggling with this condition. The study found that patients who received sarecycline for up to 40 weeks experienced low rates of side effects, with nasopharyngitis, upper respiratory tract infection, headache, and nausea being the most common. The lack of significant phototoxicity suggests that sarecycline can be used safely by patients who are concerned about sun sensitivity.
Sarecycline: A Potential New Weapon in the Fight Against Acne
This study brings good news to the millions of people who struggle with acne. Sarecycline is a potential new weapon in the fight against this stubborn skin condition, offering a new option for patients who are looking for effective and safe treatment. While more research is needed to fully understand the long-term effects of sarecycline, this study provides a promising glimpse into the future of acne treatment. Remember, it's always a good idea to talk to your doctor about the best treatment options for you.
Dr.Camel's Conclusion
Sarecycline is a promising new treatment for acne that has shown good efficacy and tolerability in a Phase III study. The results suggest that sarecycline may be a valuable addition to the treatment arsenal for acne. As with any new medication, it's important to discuss the risks and benefits of sarecycline with your doctor.
Date :
- Date Completed n.d.
- Date Revised 2020-09-28
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.